Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2010
09/28/2010CA2377605C Stable benzimidazole formulation
09/28/2010CA2376304C Amide substituted imidazoquinolines
09/28/2010CA2308201C Use of anti-fungal agents for the treatment of fungus-induced mucositis
09/28/2010CA2285746C Osteoprotegerin binding proteins and receptors
09/28/2010CA2235866C Methods of treating established colitis using antibodies against il-12
09/28/2010CA2153494C Novel parasitic helminth proteins
09/28/2010CA2103107C New amidation process
09/27/2010CA2697867A1 Multi-portion intra-oral dosage form with organoleptic properties
09/27/2010CA2692917A1 Low-swelling biocompatible hydrogels
09/24/2010CA2719523A1 Polymorphic forms of 4-phenylamino quinazoline derivatives, the preparation methods and uses thereof
09/23/2010WO2010108192A1 Mirnas as therapeutic targets in cancer
09/23/2010WO2010108190A1 Prenylated bisphosphonates as anti-tuberculosis agents
09/23/2010WO2010108155A1 Modulators of cystic fibrosis transmembrane conductance regulator
09/23/2010WO2010108125A2 Psma-targeting compounds and uses thereof
09/23/2010WO2010108115A1 Allosteric jnk inhibitors
09/23/2010WO2010108107A1 Polymorphs of fluticasone furoate and processes for preparation thereof
09/23/2010WO2010108103A1 Azepan-2-one derivatives
09/23/2010WO2010108098A1 Countermeasure methods and devices
09/23/2010WO2010108077A2 Controlled release particulates containing water-insoluble drug
09/23/2010WO2010108067A1 Alpha-(n-benzenesulfonamido)cycloalkyl derivatives
09/23/2010WO2010108060A1 Fatty acid monoglyceride compositions
09/23/2010WO2010108052A2 Amide derivatives as neuropeptide y5 receptor ligands
09/23/2010WO2010108035A1 Compounds and methods for modulating toxic and proinflammatory effects
09/23/2010WO2010108028A2 Compositions comprising cyclic amp enhancers and/or ep ligands, and methods of preparing and using the same
09/23/2010WO2010108016A2 Compositions and methods for sparing muscle in renal insufficiency and during hemodialysis
09/23/2010WO2010107997A1 Thiophenyl sulfonamides for the treatment of alzheimer's disease
09/23/2010WO2010107984A1 Novel alpha-(n-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production a novel alpha-(n-sulfonamido) acetamide compound incorporating deuterium as inhibitor of beta amyloid peptide production
09/23/2010WO2010107969A1 Improved chemical synthesis of diazaindoles by chichibabin cyclization
09/23/2010WO2010107968A1 Combination cancer therapy comprising administration of an egfr inhibitor and an igf-1r inhibitor
09/23/2010WO2010107966A1 Pharmaceutical composition comprising aliskiren
09/23/2010WO2010107958A1 RNA INTERFERENCE MEDIATED INHIBITION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 6 (STAT6) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/23/2010WO2010107957A2 RNA INTERFERENCE MEDIATED INHIBITION OF GATA BINDING PROTEIN 3 (GATA3) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/23/2010WO2010107952A2 RNA INTERFERENCE MEDIATED INHIBITION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/23/2010WO2010107909A2 Methods and compositions for the detection of cancer
09/23/2010WO2010107866A2 Catecholamine derivatives for obesity and neurological disorders
09/23/2010WO2010107838A1 Targeting apolipoprotein b for the reduction of apolipoprotein c-iii
09/23/2010WO2010107815A1 Neuroactive steroid compositions and methods of use therefor
09/23/2010WO2010107809A2 Methods for preparing dpp-iv inhibitor compounds
09/23/2010WO2010107807A2 Compounds for treating inflammation and pain
09/23/2010WO2010107794A2 Compositions and methods for delivering an agent to a wound
09/23/2010WO2010107769A2 Tire cords
09/23/2010WO2010107768A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010WO2010107765A1 Bicyclic compounds as inhibitors of diacylglycerol acyltransferase
09/23/2010WO2010107742A2 Methods and compositions of treating a flaviviridae family viral infection
09/23/2010WO2010107739A2 Methods and compositions of treating a flaviviridae family viral infection
09/23/2010WO2010107704A2 Ellipticine compounds for treating obesity
09/23/2010WO2010107689A1 Ophthalmic formulations of cetirizine and methods of use
09/23/2010WO2010107610A1 Method for treatment of diabetes and related conditions with combination therapy and compositions containing such compounds
09/23/2010WO2010107525A1 Ophthalmic formulations of ketotifen and methods of use
09/23/2010WO2010107508A1 Inhibiting gsnor
09/23/2010WO2010107488A1 Reversible nondepolarizing neuromuscular blockade agents and methods for their use
09/23/2010WO2010107485A1 E3 ligase inhibitors
09/23/2010WO2010107476A1 Inhibiting gsnor
09/23/2010WO2010107475A1 Pure antiestrogens for breast cancer therapy
09/23/2010WO2010107474A1 Antiestrogens for breast cancer therapy
09/23/2010WO2010107435A1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
09/23/2010WO2010107404A1 Stable pharmaceutical combinations
09/23/2010WO2010107397A1 Modulators of apoptosis and the uses thereof
09/23/2010WO2010107384A1 Aspartyl protease inhibitors
09/23/2010WO2010107307A1 Kit of parts comprising l-glutamine and egcg
09/23/2010WO2010107251A2 Pharmaceutical composition used in prophylaxis or treatment of hyperproliferative skin conditions and malignant melanomas comprising pachastrissamine as active ingredient
09/23/2010WO2010107225A2 Pharmaceutical composition for preventing and treating arthritis, containing sulforaphane as an effective ingredient
09/23/2010WO2010107177A2 Composition for prevention or treatment of obesity, dyslipidemia, fatty liver or insulin resistance syndrome comprising camphene as active ingredients
09/23/2010WO2010107170A1 Composition for treating metabolic diseases
09/23/2010WO2010107115A1 Glycine transporter inhibitor
09/23/2010WO2010107081A1 Solid preparation stably preserved in packaging
09/23/2010WO2010107069A1 Amino acid-containing ophthalmic composition
09/23/2010WO2010107040A1 Solid preparation containing npy y5 receptor antagonist
09/23/2010WO2010106988A1 Amide derivative
09/23/2010WO2010106981A1 Base material for spraying comprising low-molecular gelling agent
09/23/2010WO2010106904A1 Hair growing and nourishing agent, hair growing and nourishing composition, and nt-4 expression inhibitor
09/23/2010WO2010106871A1 Osmotic pressure-controlling agent
09/23/2010WO2010106798A1 Agent for promoting energy consumption
09/23/2010WO2010106571A2 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids
09/23/2010WO2010106519A1 A dose of ave5026 for the treatment of venous thromboembolism in patients with severe renal impairment
09/23/2010WO2010106503A1 A dermaceutical cream made using sodium fusidate, miconazole nitrate and mometasone furoate
09/23/2010WO2010106502A1 A novel dermaceutical cream made using sodium fusidate, clotrimazole and clobetasol propionate, a process to make the same and a method of treatment using it
09/23/2010WO2010106494A1 Use of pharmaceutical compositions containing mesembrenone
09/23/2010WO2010106465A1 A dermaceutical cream made using sodium fusidate, clotrimazole and fluticasone propionate
09/23/2010WO2010106462A1 A dermaceutical cream made using sodium fusidate and mometasone furoate
09/23/2010WO2010106461A1 A dermaceutical cream made using sodium fusidate and fluticasone propionate
09/23/2010WO2010106460A1 A dermaceutical cream made using sodium fusidate, miconazole nitrate and fluticasone propionate
09/23/2010WO2010106459A1 A dermaceutical cream made using sodium fusidate, clotrimazole and mometasone furoate
09/23/2010WO2010106458A1 A dermaceutical cream made using sodium fusidate and betamethasone valerate
09/23/2010WO2010106436A2 Novel anti-inflammatory agents
09/23/2010WO2010106420A1 Method of treating nonalcoholic steatohepatitis with elevated doses of ursodeoxycholic acid
09/23/2010WO2010106384A1 Glucooligosaccharide nutraceutical, pharmaceutical, or food compositions
09/23/2010WO2010106383A1 Novel crystalline form of antiprogestin cdb-4124
09/23/2010WO2010106366A1 Fk506 and fk520 analogues and their pharmaceutical uses
09/23/2010WO2010106355A1 Compound for the treatment of tuberculosis
09/23/2010WO2010106341A1 Compounds and biological materials and uses thereof
09/23/2010WO2010106333A1 Compounds
09/23/2010WO2010106313A1 Improvement in solubility of drugs by means of hyaluronic acid
09/23/2010WO2010106290A1 Hsp90 inhibiting indazole derivatives, compositions containing same and use thereof
09/23/2010WO2010106285A1 Methods for measuring the intracellular quantity of intrinsically fluorescent molecules of interest by means of flow cytometry and uses thereof
09/23/2010WO2010106270A1 N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same
09/23/2010WO2010106269A2 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
09/23/2010WO2010106249A1 Benzothiadiazepine derivatives used as ampa and nmda receptor modulators
09/23/2010WO2010106211A1 Use of derivatives of polyunsaturated fatty acids as medicaments
09/23/2010WO2010106209A1 Use of a compound for the treatment of a lesion produced by postischemic reperfusion
1 ... 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 ... 7860